Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GSK

Top 3 Smart Pharma Picks for Good Investments

As global medical needs and technology evolve, the pharmaceutical industry is expected to thrive. Therefore, fundamentally strong pharma stocks Eli Lilly (LLY), AstraZeneca (AZN) and GSK (GSK) might be ideal additions to your portfolio. Read on.

StockNews.com

Obesity drug boom pushes Novo Nordisk shares to record high

Market value of Danish drugmaker behind Wegovy and Ozempic tops $500bn as demand soars

The Guardian - UK

Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short.

Teva stock neared a profit-taking zone Wednesday, while GSK stock bounded briefly out of a chase zone on strong fourth-quarter performances for both.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

FTSE 100 Live 31 January: US Fed holds rates, London index closes down after late slide

The property market’s new year resilience and upgraded GSK targets are in focus ahead of tonight's US interest rates decision.

Evening Standard

GSK surpasses Q4 estimates, projects 2024 growth

GSK's fourth-quarter results exceeded expectations, signaling company growth in 2024. Learn more about the positive financial outlook for GSK.

Top News

AstraZeneca buys US vaccine company in $1.1bn deal

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

The Guardian - UK

3 Pharma Stocks Flashing 'Buy' Signals in December

The pharmaceutical industry is well-positioned for robust growth, driven by growing healthcare expenditure globally and the rapid adoption of digital technologies. Given the industry’s tailwinds, fundamentally strong pharma stocks, Collegium Pharmaceutical (COLL), Eton Pharmaceuticals (ETON), and GSK plc (GSK) could be ideal buys this month. Continue Reading….

StockNews.com

1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach for its vaccines.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Pharma Stocks on the Rise - It's Time to Buy Now

The pharma industry’s long-term solid outlook is driven by steady demand for drugs due to the rising frequency of chronic conditions and growing geriatric population coupled with rapid technological innovations. Hence, quality pharma stocks, CytomX Therapeutics (CTMX), Eton Pharmaceuticals (ETON), and GSK (GSK), might be solid investments now for potential…

StockNews.com

SNDL Inc. (SNDL) vs. GSK plc (GSK): Analyzing the Better Long-Term Pharma Investment

Amid the burgeoning technological innovation and its seamless integration, investors' interest seems to gravitate toward the pharmaceutical industry. Keeping this in mind, which of the stocks, SNDL Inc. (SNDL) and GSK plc (GSK), could be a better long-term investment? Let's find out.

The Guardian - US

Poor people in the developing world have a right to medicine

People should not die because of their income or where they were born. We must have the courage to stand up to the pharmaceutical industry

StockNews.com

3 Pharma Stocks to Capitalize on With Potential Upside

The pharma industry’s prospects look bright, thanks to rising demand for innovative drugs. Thus, pharma stocks with potential upside, like GSK plc (GSK), Johnson & Johnson (JNJ), and Bristol-Myers Squibb Company (BMY), could be wise investments to capitalize on right now. Read on….

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors Business Daily

GSK Dives As Shingrix Comes In Light Despite Strong RSV Vaccine Launch

GSK raised its outlook for the second time this year on the back of a strong launch for its RSV vaccine. But GSK stock fell.

The Conversation

We could see thunderstorm asthma in south-eastern Australia this season – here's how to prepare

Victorians have been warned to prepare for the possibility of thunderstorm asthma again this season.

StockNews.com

3 Promising Pharma Stocks to Keep on Your Radar

The pharma industry’s prospects look bright, thanks to rising demand for generic and innovative drugs and technological advancements. Hence, adding fundamentally strong pharma stocks Astellas Pharma (ALPMY), Sanofi (SNY), and GSK (GSK) to one’s watchlist could be wise. Keep reading.

Salon

Big Pharma slowed vaccine development

A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests

The Independent UK

UN authorizes a second malaria vaccine. Experts warn it's not enough to stop the disease spreading

The World Health Organization has authorized a second malaria vaccine in a decision that could offer countries a cheaper and more effective option than the world’s first shot against the parasitic disease

The Guardian - UK

People with HIV offered hope of self-injected drug at home

GSK-controlled company works on developing patient-administered treatment by end of the decade

1 … 4 5 6 7

People

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.